Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

2.

Sentinel Lymph Node Biopsy Should Be Included with the Initial Surgery for High-Risk Ductal Carcinoma-In-Situ.

Tan EY, Lo ZW, Ang CH, Teo C, Seah MD, Chen JJ, Chan PM.

Int Sch Res Notices. 2014 Oct 29;2014:624185. doi: 10.1155/2014/624185.

3.

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.

van Roozendaal LM, Goorts B, Klinkert M, Keymeulen KB, De Vries B, Strobbe LJ, Wauters CA, van Riet YE, Degreef E, Rutgers EJ, Wesseling J, Smidt ML.

Breast Cancer Res Treat. 2016 Apr;156(3):517-25. doi: 10.1007/s10549-016-3783-2.

4.

Sentinel lymph node biopsy in clinically detected ductal carcinoma in situ.

Al-Ameer AY, Al Nefaie S, Al Johani B, Anwar I, Al Tweigeri T, Tulbah A, Alshabanah M, Al Malik O.

World J Clin Oncol. 2016 Apr 10;7(2):258-64. doi: 10.5306/wjco.v7.i2.258.

5.

Sentinel lymph node biopsy in patients with breast ductal carcinoma in situ: Chinese experiences.

Sun X, Li H, Liu YB, Zhou ZB, Chen P, Zhao T, Wang CJ, Zhang ZP, Qiu PF, Wang YS.

Oncol Lett. 2015 Sep;10(3):1932-1938.

6.

Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?

Francis AM, Haugen CE, Grimes LM, Crow JR, Yi M, Mittendorf EA, Bedrosian I, Caudle AS, Babiera GV, Krishnamurthy S, Kuerer HM, Hunt KK.

Ann Surg Oncol. 2015 Dec;22(13):4270-9. doi: 10.1245/s10434-015-4547-7.

7.

Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases.

Matsen CB, Hirsch A, Eaton A, Stempel M, Heerdt A, Van Zee KJ, Cody HS 3rd, Morrow M, Plitas G.

Ann Surg Oncol. 2014 Oct;21(10):3330-5. doi: 10.1245/s10434-014-3920-2.

8.

Intracystic papillary carcinoma of breast: report of three cases and review of the literature.

Dhebri AR, Ahmad A, Shah N, Arora PK.

BMJ Case Rep. 2012 Nov 27;2012. pii: bcr2012007237. doi: 10.1136/bcr-2012-007237. Review.

9.

Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy.

Shah DR, Canter RJ, Khatri VP, Bold RJ, Yang AD, Martinez SR.

Ann Surg Oncol. 2013 Jan;20(1):24-30. doi: 10.1245/s10434-012-2539-4.

10.

Memorial sloan-kettering cancer center: two decades of experience with ductal carcinoma in situ of the breast.

Choi DX, Van Zee KJ.

Int J Surg Oncol. 2012;2012:723916. doi: 10.1155/2012/723916.

11.

Sentinel Lymph Node Biopsy in Pure DCIS: Is It Necessary?

Boler DE, Cabioglu N, Ince U, Esen G, Uras C.

ISRN Surg. 2012;2012:394095. doi: 10.5402/2012/394095.

12.
13.

Ductal carcinoma in situ and sentinel lymph node biopsy.

Son BK, Bong JG, Park SH, Jeong YJ.

J Breast Cancer. 2011 Dec;14(4):301-7. doi: 10.4048/jbc.2011.14.4.301.

14.

Role of axillary staging in women diagnosed with ductal carcinoma in situ with microinvasion.

Pimiento JM, Lee MC, Esposito NN, Kiluk JV, Khakpour N, Carter WB, Han G, Laronga C.

J Oncol Pract. 2011 Sep;7(5):309-13. doi: 10.1200/JOP.2010.000096.

15.

Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ.

Shapiro-Wright HM, Julian TB.

J Natl Cancer Inst Monogr. 2010;2010(41):145-9. doi: 10.1093/jncimonographs/lgq026. Review.

16.

The impact of sentinel lymph node biopsy and magnetic resonance imaging on important outcomes among patients with ductal carcinoma in situ.

Tuttle TM, Shamliyan T, Virnig BA, Kane RL.

J Natl Cancer Inst Monogr. 2010;2010(41):117-20. doi: 10.1093/jncimonographs/lgq023. Review.

17.

Recent advances in the surgical care of breast cancer patients.

Mascaro A, Farina M, Gigli R, Vitelli CE, Fortunato L.

World J Surg Oncol. 2010 Jan 20;8:5. doi: 10.1186/1477-7819-8-5. Review.

18.

The sentinel node in breast cancer.

Collins CD.

Cancer Imaging. 2008 Oct 4;8 Spec No A:S10-8. doi: 10.1102/1470-7330.2008.9003. Review.

19.

Intracystic papillary carcinoma: a review of 917 cases.

Grabowski J, Salzstein SL, Sadler GR, Blair S.

Cancer. 2008 Sep 1;113(5):916-20. doi: 10.1002/cncr.23723.

20.

Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer.

Yi M, Krishnamurthy S, Kuerer HM, Meric-Bernstam F, Bedrosian I, Ross MI, Ames FC, Lucci A, Hwang RF, Hunt KK.

Am J Surg. 2008 Jul;196(1):81-7. doi: 10.1016/j.amjsurg.2007.08.057.

Supplemental Content

Support Center